UK generics industry: "Let's shut the stable door before the horse bolts"
This article was originally published in SRA
The British Generic Manufacturers Association says it is working with the government to address long term issues affecting generics companies before they start to affect the sustainability of the industry1. Increasing pricing pressures, intellectual property rights issues and current levels of competition could all conspire to threaten the industry if action is not taken immediately, said the association at its annual general meeting.
You may also be interested in...
Softening provisions to make EU-wide joint clinical assessments voluntary would make proposed legislation on HTA cooperation redundant, says Eurordis.
Plans for EU-wide Joint Clinical assessments will come under scrutiny at an EU council meeting next week.
Pfizer’s Ibrance has won conditional reimbursement in England while more data is gathered to reduce some uncertainty.